Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Neuro-Oncology|October 3, 2013
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumoursJustyna Kmiecik, Jacques Zimmer, Martha ChekenyaOncoimmunology|February 28, 2014
Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastomaJustyna Kmiecik, Andrea Gras Navarro, Aurelie Poli, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
NK cells in central nervous system disordersAurélie Poli, Justyna Kmiecik, Olivia Domingues, et al.Blood|July 29, 2011
Erythrocyte peripheral type benzodiazepine receptor/voltage-dependent anion channels are upregulated by Plasmodium falciparumGuillaume Bouyer, Anne Cueff, Stéphane Egée, et al.Journal of Neuroimmunology|September 19, 2013
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic levelJustyna Kmiecik, Aurélie Poli, Nicolaas H C Brons, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survivalAndrea Gras Navarro, Justyna Kmiecik, Lina Leiss, et al.Plos One|August 11, 2011
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanomaJian Wang, Agnete Svendsen, Justyna Kmiecik, et al.Acta Neuropathologica|August 25, 2011
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastomaAgnete Svendsen, Joost J C Verhoeff, Heike Immervoll, et al.Immunotherapy Advances|January 2, 2026
Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumorsMargherita Boieri, Justyna Kmiecik, Maja Sandve, et al.Pageof 1